Unlock Your Specialty Pharmacy’s Hidden Value [INFOGRAPHIC]https://shieldshealthsolutions.com/content/uploads/2026/01/Blog-icon-for-social-200x200-1.png200200Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
See how your health system can retain specialty volume, strengthen financial performance, and improve patient outcomes with the right strategy and support. Health systems without fully integrated specialty pharmacy models…
Shields Health Solutions Partners with Foundation Health, the Leading Pharmacy AI Platform, to Improve Patient and Provider Experience in Specialty Pharmacy Care Nationwidehttps://shieldshealthsolutions.com/content/uploads/2025/05/PR-1024x1024.png10241024Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
The partnership, and investment from Shields, aims to enhance workflows for high-touch medications with innovative pharmacy operations technology, improving patient experience and reducing administrative burden STOUGHTON, Mass. (Jan. 13, 2026)…
Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happeninghttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2025 marked its 21st anniversary — and we couldn’t be…
Shields Health Solutions and Lakeland Regional Health Collaborate to Enhance Patient Access to Specialty Pharmacy Carehttps://shieldshealthsolutions.com/content/uploads/2025/05/PR-1024x1024.png10241024Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
The partnership will support patients through personalized care, medications, and coordinationShields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of…
Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacieshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.
Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medicationshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.
Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditationhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.
Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).
Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancerhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg